- MS in Bioengineering, University of Washington
- BS in Bioengineering, Rice University
Jeremy has 11 years of experience in health care and strategy across the areas of biotechnology drugs, corporate venture capital, and investment banking. Most recently, he worked at Genentech, focusing on oncology strategy through market research, sales performance analytics, and drug launch initiatives. He worked with senior executives, leading high-priority drug-launch and sales-performance initiatives. Before that, he worked at General Electric’s GE Ventures, where he led sourcing, investment, portfolio management, and due diligence activities. At Credit Suisse, he performed equity research in U.S. pharmaceuticals and in life sciences tools, and handled health care mergers and acquisitions. Jeremy has been a key supporter of social impact programs through leadership and mentoring.